AIRS Nasdaq Earnings call
Airsculpt Technologies, Inc. (AIRS) · Q2 2026 results and valuation
Share price: $0.81 · 2026-11-11
Results Q2 2026 vs Q4 2025 · previous quarter · published 10 Aug 2026 and 2 Apr 2026
Management sounded upbeat, in its script and in answers to analysts.
Only a basic analysis is available for this company at the moment.
1 · Numbers
—
No financial figures for this pair
Outlook given
2 · How management spoke
Upbeat
More upbeat than 67% of company calls
Answers to analysts: restrained, in line with the script.
Similar to last call.
3 · What stood out
Key theme
AIRS will start treating patients with AlloClae later this quarter at roughly 60% gross margin, similar to existing services, and that margin has…
Valuation
Is Airsculpt Technologies, Inc. undervalued?
Reverse DCF. Free cash flow from the last full fiscal year (2025-12-31), grown for 10 years, discounted back, plus a terminal value. “Implied growth” is the rate the current price assumes.
The projected cash flow doesn't cover the debt, so the price is far above the model's fair value.
Current price
$0.81
close of 2026-11-11
Market implies growth of iThe yearly free-cash-flow growth, for the next 10 years, that today’s share price already assumes. If you believe the company grows faster than this, the stock is cheap under this model; slower, and it is expensive.
+32.5% for 10 yrs
Fair value / share
$-0.26
Buy below
$-0.19
Price vs fair value
n/a
Price vs buy-below price
n/a
Read between the lines
-
Guidance
As you saw in its earnings release, Airsculpt Technologies is reaffirming its outlook at the lower end of its revenue guidance and updating its adjusted EBITDA outlook to a range…
-
Guidance
AIRS expects higher returns from fine-tuned marketing spend to drive revenue growth and greater marketing efficiency.
Source quote
“As we fine-tune our marketing investments in these procedures, we expect to achieve a higher return on that spend, driving revenue growth and greater marketing efficiency.”
-
Figure
AIRS same-store sales improved from down 22% at the start of 2025 to positive in Feb, signaling a stabilized core business.
Source quote
“Our core business has stabilized with same-store sales improving from down 22% at the start of 2025 to positive in Feb...”
-
Fading
As mentioned in the past, debt reduction has been the focus of Airsculpt Technologies' capital allocation strategy.
Source quote
“As mentioned in the past, debt reduction has been the focus of our capital allocation strategy. Turning to our third area of focus, maintaining strong financial discipline, both in our margins and capital allocation. We repaid over $30 million of debt over the last 5 quarters, bringing our leverage below 2.5 as of the current date.”
Tone
How upbeat the language was, compared with other companiesiTone counts positive minus negative finance words, adjusted for length. Executives mostly speak positively, so the labels compare each call with every company's latest call: “typical” is the middle third, “very upbeat” the top tenth, “cautious” the bottom tenth.. Dot: Q2 2026. Ring: Q4 2025.
Script and answers carried a similar tone, so the script's message held up under questioning.
Sentences that drove the tone
“As we fine-tune our marketing investments in these procedures, we expect to achieve a higher return on that spend, driving revenue growth and greater marketing efficiency.”
“Convert the stabilization achieved year-to-date into sustained profitable growth.”
“Over the past 18 months, we have broadened our consumer reach to capture the growing opportunity presented by GLP-1 patients, bolstered our talent, invested in new marketing strategies, and strengthened...”
Topics
Most discussed now
- Airsculpt Technologies attributes that to the fact that it is just executing a transformation in a choppy consumer environment, frankly, so…
- New The decline in average selling price was primarily driven by Airsculpt Technologies' comparison against an unusually high average selling…
- These statements may include Airsculpt Technologies' future expectations regarding financial results and guidance, market opportunities…
- Center sales began the quarter positively and saw moderating sales trends in June, which Airsculpt Technologies attributes to a dynamic…
- Over the past 18 months, Airsculpt Technologies has broadened its consumer reach to capture the growing opportunity presented by GLP-1…
Faded since Q4 2025
- Dropped With attractive clinic level contribution margins and a significant white space for expansion, both geographically and across adjacent…
- Fading AirSculpt combines strong unit level performance, a differentiated offering and a brand with the right to win in a growing...
- Fading At the same time, Airsculpt Technologies does recognize that it must deliver consistent results to make sure that it can hit...
- Fading They are getting good results from the procedures.
Latest announcements
Official filings, newest first.
- Other events · SEC 8-K
- Results of operations · SEC 8-K
- Shareholder vote results · SEC 8-K
- Results of operations · SEC 8-K
- Results of operations · SEC 8-K
- Results of operations · SEC 8-K
- Director or officer change · SEC 8-K
- Results of operations; Director or officer change · SEC 8-K